Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    16957145 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Gossypol;   Drug: Placebo
2 Completed Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: etoposide;   Drug: vinblastine sulfate;   Drug: vindesine;   Drug: vinorelbine tartrate;   Radiation: radiation therapy
3 Active, not recruiting TAilored Post-Surgical Therapy in Early Stage NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Standard Chemotherapy;   Drug: Customized Treatment

Indicates status has not been verified in more than two years